Axonics Acquires Contura Ltd (Bulkamid)

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

Nexxus Iberia Acquires CONTENUR from ACON Investments

July 29, 2024

Manufacturing

Nexxus Iberia Private Equity Fund II has acquired CONTENUR, a leading European manufacturer and servicer of containers for municipal waste collection and recycling, from ACON Investments. Schroders and the European Investment Fund joined as equity partners, management remains a significant shareholder; financial terms were not disclosed.

Institutional Investors Advised by J.P. Morgan Asset Management Acquire Contanda from EQT Infrastructure

December 18, 2019

Logistics & Distribution

EQT Infrastructure II has completed the sale of Contanda LLC, a Houston-based provider of liquid bulk storage and logistics services, to institutional investors advised by J.P. Morgan Asset Management. Contanda operates 15 terminals in North America with over seven million barrels of capacity and ~275 employees; the sale represents a PE exit after a period of growth and capacity expansion under EQT's ownership.

Axonius Acquires Cynerio

July 30, 2025

Cybersecurity

Axonius has acquired Cynerio, a specialist in medical-device and healthcare IoT security, to accelerate the company's expansion into the healthcare market. Deal terms were reported at about $180 million (potentially rising to $250 million on milestones), while Axonius' announcement described the transaction as "more than $100 million" in a cash-and-stock deal.

Zydus Lifesciences Acquires Agenus' U.S. Biologics Manufacturing Facilities and Launches Zylidac Bio LLC

January 16, 2026

Biotechnology

Zydus Lifesciences Limited has completed purchase agreements with Agenus Inc. to acquire Agenus' biologics manufacturing facilities and operations in Emeryville and Berkeley, California, and has established a U.S. CDMO subsidiary, Zylidac Bio LLC, to operate the assets. The deal includes exclusive manufacturing arrangements for Agenus' Phase 3 immuno-oncology candidates (botensilimab and balstilimab), exclusive commercialization rights for those assets in India and Sri Lanka, and an equity investment in Agenus via Zynext Ventures; regulatory approvals including CFIUS clearance were secured.

Murphy Canyon Acquisition Corp. Completes Business Combination with Conduit Pharmaceuticals

September 22, 2023

Pharmaceuticals

Murphy Canyon Acquisition Corp. (MURF) completed its previously announced business combination with Conduit Pharmaceuticals Limited, resulting in the combined company trading on Nasdaq under the ticker CDT and a pro forma enterprise value of approximately $720 million. A single institutional investor purchased $20.0 million of MURF units in a private placement, and the combined transaction and offering provided Conduit with roughly $20 million of cash (after redemptions, before transaction expenses).